Search Login Register
Pulmonary venous return anomaly
Summary
Description:
merge
Also Known As:
Anomalous pulmonary venous return; Scimitar anomaly; TAPVR; TAPVR1; Total anomalous pulmonary venous return
Networked: 351
relevant articles (3 outcomes,
5 trials/studies)
for this Bio-Agent
Key Diseases for which Pulmonary venous return anomaly is
Relevant
-
Atrial Heart Septal Defects (Atrial Septal Defect)
:
1 outcome 1 study in 79 results
-
Hypertrophy
:
1 outcome in 2 results
-
False Aneurysm (Pseudoaneurysm)
:
1 outcome in 1 result
-
Tetralogy of Fallot (Fallot Tetralogy)
:
1 study in 44 results
-
Ventricular Heart Septal Defects (Ventricular Septal Defect)
:
1 study in 43 results
Show All >>
Drugs Related to Pulmonary venous return anomaly
-
Complete atrioventricular septal defect
-
4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid
-
Pulmonary venous return anomaly
-
Coarctation of the aorta
-
tranilast (N 5')
-
Nitric Oxide (Nitrogen Monoxide)
-
Lung agenesis
-
Epoprostenol (Prostacyclin)
-
Coenzyme A (CoA)
-
Brain Natriuretic Peptide (Natrecor)
Show All >>
Therapies Related to Pulmonary venous return anomaly
-
Fontan Procedure (Fontan Operation)
-
Pneumonectomy (Lung Volume Reduction)
-
Ligation
-
Blalock-Taussig Procedure
-
Transplants (Transplant)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.